ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 088,24
0,89%
Dow Jones
38 239,66
0,40%
DAX
18 161,01
1,32%
Brent Oil
88,165
0,00%
Bitcoin
63 842,53
0,68%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Innoviva Inc (INVA)

  7. Innoviva Inc (INVA) Actualités

INVA Innoviva Inc

15,26
0,27 (1,80%)
26 Avr 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Innoviva Inc INVA NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,27 1,80% 15,26 23:16:11
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
15,01 14,98 15,285 15,26 14,99
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
24/4/202413:00BWInnoviva Specialty Therapeutics’ Positive Phase 3 Oral..
08/3/202401:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202401:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202401:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202400:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202423:01EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29/2/202422:15EDGAR2Form 8-K - Current report
29/2/202422:05BWInnoviva Reports Fourth Quarter and Full Year 2023 Financial..
23/2/202403:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202403:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202413:23EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
23/1/202403:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/1/202402:26EDGAR2Form 3 - Initial statement of beneficial ownership of..
17/11/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/11/202314:30EDGAR2Form 8-K - Current report
01/11/202321:30EDGAR2Form 8-K - Current report
01/11/202321:15BWInnoviva Reports Third Quarter 2023 Financial Results and..
01/11/202321:05BWPositive Results Announced in Largest Pivotal Phase 3 Trial..
19/9/202314:30BWInnoviva to Participate in the Cantor Global Healthcare..
18/9/202314:00BWXACDURO®, The First and Only Antibiotic Developed to Target..
01/9/202302:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/8/202319:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/8/202323:24EDGAR2Form 8-K - Current report
25/8/202322:52BWInnoviva Appoints Stephen Basso as Chief Financial Officer
07/8/202322:42EDGAR2Form 8-K - Current report
03/8/202303:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/8/202322:15EDGAR2Form 8-K - Current report
02/8/202322:05BWInnoviva Reports Second Quarter 2023 Financial Results and..
11/7/202314:16EDGAR2Form 8-K - Current report
06/6/202322:05BWInnoviva to Participate in the Goldman Sachs Annual Global..
24/5/202301:10DJNFDA Approves Innoviva's Bacterial Pneumonia Treatment
24/5/202300:42BWInnoviva Specialty Therapeutics Announces FDA Approval for..
12/5/202300:45BWResults from Pivotal Phase 3 ATTACK Trial of Investigational..
09/5/202322:32BWInnoviva Reports First Quarter 2023 Financial Results and..

Dernières Valeurs Consultées

NASDAQ
INVA
Innoviva
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés